Advances in tetrahydropyrido[1,2-a]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitors.

Abstract : An efficient synthetic strategy was developed to modulate the structure of the tetrahydropyridine isoindolone (Valmerin) skeleton. A library of more than 30 novel final structures was generated. Biological activities on CDK5 and GSK3 as well as cellular effects on cancer cell lines were measured for each novel compound. Additionally docking studies were performed to support medicinal chemistry efforts. A strong GSK3/CDK5 dual inhibitor (38, IC50 GSK3/CDK5 32/84 nM) was obtained. A set of highly selective GSK3 inhibitors was synthesized by fine-tuning structural modifications (29 IC50 GSK3/CDK5 32/320 nM). Antiproliferative effects on cells were correlated with the in vitro kinase activities and the best effects were obtained with lung and colon cell lines.
Type de document :
Article dans une revue
European Journal of Medicinal Chemistry, Elsevier, 2015, 101, pp.274-287. 〈10.1016/j.ejmech.2015.06.046〉
Liste complète des métadonnées

Littérature citée [27 références]  Voir  Masquer  Télécharger

https://hal.archives-ouvertes.fr/hal-01212495
Contributeur : Stéphanie Bonnefoy <>
Soumis le : jeudi 19 novembre 2015 - 15:06:32
Dernière modification le : vendredi 26 octobre 2018 - 16:56:01

Fichier

Advances in Tetrahydropyrido.p...
Fichiers produits par l'(les) auteur(s)

Identifiants

Citation

Rajâa Boulahjar, Aziz Ouach, Stéphane Bourg, Pascal Bonnet, Olivier Lozach, et al.. Advances in tetrahydropyrido[1,2-a]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitors.. European Journal of Medicinal Chemistry, Elsevier, 2015, 101, pp.274-287. 〈10.1016/j.ejmech.2015.06.046〉. 〈hal-01212495〉

Partager

Métriques

Consultations de la notice

630

Téléchargements de fichiers

204